search
Back to results

Effect of the Omentectomy on the Hyperglycemia and the Resistance to the Insulin in Patients With Morbid Obesity (omentectomy)

Primary Purpose

Obesity, Diabetes Mellitus Type 2

Status
Completed
Phase
Early Phase 1
Locations
Mexico
Study Type
Interventional
Intervention
omentectomy
Sponsored by
Universidad de Guanajuato
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional prevention trial for Obesity

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • All the patients with Obesity Morbid who suffer of hernia umbilical Chronic Cholecystitis Lithiasic non worsened.
  • Patient with age between the 18 to 55 years of age.
  • Both sorts.
  • Patient with index of corporal mass from 30 to 35.
  • Patient with index waist greater or equal hip of 100cm in men and women greater of 88cm.
  • Patient that has a central glucose of 100 to 125mg.
  • Patient that has a tolerance to the glucose of 140 to 200mg.
  • Patient which they have a result of triglyceride in blood of 300 or greater.
  • Patient that has values of LHD below 40 mg/dl.

Exclusion Criteria:

  • Patient that they have I diagnose already established of Diabetes Mellitus type 2 and in medical treatment.
  • Patient with elevation of hepátic enzymes (more than 50% of the superior limits of normality) and/or creatinin in 1,5 serum > mg/Dl.
  • Patient with Diabetic ketoacidosis history.
  • Uso of oral anticoagulants.
  • Positive Test of pregnancy (Human Chorionic Gonadotropin ) for women.
  • Recurrent Infections and at the time of the study.
  • Umbilical Hernia complicated and strangled or Worsened Chronic Cholecystitis.

Sites / Locations

  • Hospital General Regional de León, Universidad de Guanajuato, Facultad de Medicina de León

Outcomes

Primary Outcome Measures

To compare the Blood levels of of glucose, curve of tolerance wing glucose, hemoglobin glycosylated, insulin, triglyceride, cholesterol, HDL, LDL, leptin and Adiponectin before and after the procedure

Secondary Outcome Measures

To evaluate the metabolic conditions of the subjects of both groups to the 15 days and the month, 6, 12 and 24 months later to the procedure

Full Information

First Posted
March 27, 2007
Last Updated
May 30, 2008
Sponsor
Universidad de Guanajuato
search

1. Study Identification

Unique Protocol Identification Number
NCT00454597
Brief Title
Effect of the Omentectomy on the Hyperglycemia and the Resistance to the Insulin in Patients With Morbid Obesity
Acronym
omentectomy
Official Title
PHASE 1 The Effect of the Omentectomy on the Hyperglycemia and the Resistance to the Insulin in Patients With Morbid Obesity
Study Type
Interventional

2. Study Status

Record Verification Date
May 2008
Overall Recruitment Status
Completed
Study Start Date
February 2007 (undefined)
Primary Completion Date
March 2007 (Actual)
Study Completion Date
December 2007 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Universidad de Guanajuato

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
To determine if the omentectomy diminishes hyperglycemia and improves the resistance to the insulin in patients with morbid obesity and propensity to develop to Diabetes Mellitus type 2.
Detailed Description
To determine the Blood levels of glucose, curve of tolerance to the glucose, hemoglobin glycosylated, insulin, triglyceride, cholesterol, HDL, LDL, leptin and Adiponectin in patients with Obesity Morbid and that will be put under umbilical surgery and cholecystectomy opened. To put under them umbilical surgery or Cholecystectomy open with and without omentectomy To compare the Blood levels of of glucose, curve of tolerance wing glucose, hemoglobin glycosylated, insulin, triglyceride, cholesterol, HDL, LDL, leptin and Adiponectin before and after the procedure

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Diabetes Mellitus Type 2

7. Study Design

Primary Purpose
Prevention
Study Phase
Early Phase 1
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
21 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
omentectomy
Intervention Description
surgery omentectomy
Primary Outcome Measure Information:
Title
To compare the Blood levels of of glucose, curve of tolerance wing glucose, hemoglobin glycosylated, insulin, triglyceride, cholesterol, HDL, LDL, leptin and Adiponectin before and after the procedure
Time Frame
3 months
Secondary Outcome Measure Information:
Title
To evaluate the metabolic conditions of the subjects of both groups to the 15 days and the month, 6, 12 and 24 months later to the procedure
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: All the patients with Obesity Morbid who suffer of hernia umbilical Chronic Cholecystitis Lithiasic non worsened. Patient with age between the 18 to 55 years of age. Both sorts. Patient with index of corporal mass from 30 to 35. Patient with index waist greater or equal hip of 100cm in men and women greater of 88cm. Patient that has a central glucose of 100 to 125mg. Patient that has a tolerance to the glucose of 140 to 200mg. Patient which they have a result of triglyceride in blood of 300 or greater. Patient that has values of LHD below 40 mg/dl. Exclusion Criteria: Patient that they have I diagnose already established of Diabetes Mellitus type 2 and in medical treatment. Patient with elevation of hepátic enzymes (more than 50% of the superior limits of normality) and/or creatinin in 1,5 serum > mg/Dl. Patient with Diabetic ketoacidosis history. Uso of oral anticoagulants. Positive Test of pregnancy (Human Chorionic Gonadotropin ) for women. Recurrent Infections and at the time of the study. Umbilical Hernia complicated and strangled or Worsened Chronic Cholecystitis.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Arturo MD Reyes Hernandez, Surgery
Organizational Affiliation
Universidad de Guanajuato, Facultad de Medicina de León, Hospital General Regional de León
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital General Regional de León, Universidad de Guanajuato, Facultad de Medicina de León
City
Leon
State/Province
Guanajuato
ZIP/Postal Code
37320
Country
Mexico

12. IPD Sharing Statement

Citations:
PubMed Identifier
11850750
Citation
Thorne A, Lonnqvist F, Apelman J, Hellers G, Arner P. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord. 2002 Feb;26(2):193-9. doi: 10.1038/sj.ijo.0801871.
Results Reference
result

Learn more about this trial

Effect of the Omentectomy on the Hyperglycemia and the Resistance to the Insulin in Patients With Morbid Obesity

We'll reach out to this number within 24 hrs